Regeneron shareholders re-elect four Class I directors, approve auditor, advisory pay vote at 2022 annual meeting

REGENERON PHARMACEUTICALS, INC.

Board nominees Bassler, Brown, Schleifer, Yancopoulos re-elected with 96.9M, 86.3M, 110.1M, 109.5M votes for, respectively.
Ratification of PwC as independent auditor for FY2022 approved: 111.8M for, 4.5M against.
Advisory vote on named executive officer compensation approved: 97.8M for, 13.6M against, 4.7M broker non-votes.
All three proposals passed; no contested items or shareholder proposals on ballot.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.